Found: 14
Select item for more details and to access through your institution.
4. An innovative clinical trial designed to evaluate the effects of ACI‐24.060 in Alzheimer's Disease and in Down syndrome (ABATE Study).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.075830
- By:
- Publication type:
- Article
Update on [18F]ACI‐12589: a novel and promising PET tracer for a‐synuclein.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.073125
- By:
- Publication type:
- Article
Biomarker‐based development for optimized ACI‐24, a novel candidate vaccine for the treatment and prevention of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.065454
- By:
- Publication type:
- Article
Initial clinical scans using [<sup>18</sup>F]ACI‐12589, a novel α‐synuclein PET‐tracer.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065394
- By:
- Publication type:
- Article
Discovery of [<sup>18</sup>F]ACI‐12589, a Novel and Promising PET‐Tracer for Alpha‐Synuclein.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.064680
- By:
- Publication type:
- Article
ACI‐24 in adults with Down syndrome: Results of a phase 1b, randomized, placebo‐controlled study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057427
- By:
- Publication type:
- Article
The development of [<sup>18</sup>F]ACI‐12589, a high affinity and selective alpha‐synuclein radiotracer, as a biomarker for Parkinson's disease and other synucleinopathies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.053943
- By:
- Publication type:
- Article
Developing a novel alpha‐synuclein positron emission tomography (PET) tracer for the diagnosis of synucleinopathies: Neuroimaging: Other neurodegenerative disorders.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043249
- By:
- Publication type:
- Article
ACI‐24 vaccine in adults with Down syndrome: Human: Putative therapeutic results for Alzheimer's and related dementias.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038678
- By:
- Publication type:
- Article
Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 6, p. 565, doi. 10.1001/jamaneurol.2022.0983
- By:
- Publication type:
- Article
An International Study of the Ability and Cost-Effectiveness of Advertising Methods to Facilitate Study Participant Self-Enrolment Into a Pilot Pharmacovigilance Study During Early Pregnancy.
- Published in:
- Journal of Medical Internet Research, 2016, v. 18, n. 3, p. 63, doi. 10.2196/publichealth.5366
- By:
- Publication type:
- Article
Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy.
- Published in:
- Journal of Medical Internet Research, 2015, v. 17, n. 12, p. 1, doi. 10.2196/publichealth.4939
- By:
- Publication type:
- Article
Balancing the Interests of Patient Data Protection and Medication Safety Monitoring in a Public-Private Partnership.
- Published in:
- Journal of Medical Internet Research, 2015, v. 17, n. 5, p. 1, doi. 10.2196/medinform.3937
- By:
- Publication type:
- Article
Balancing the Interests of Patient Data Protection and Medication Safety Monitoring in a Public-Private Partnership.
- Published in:
- Journal of Medical Internet Research, 2015, v. 17, n. 4, p. 1, doi. 10.2196/medinform.3937
- By:
- Publication type:
- Article